Calamos Advisors LLC Edwards Lifesciences Corp Transaction History

Calamos Advisors LLC

$16.1 Billion
Q3 2024

A detailed history of Calamos Advisors LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Calamos Advisors LLC holds 167,722 shares of EW stock, worth $12.5 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

167,722

Previous 171,821 2.39%

Holding current value

$12.5 Million

Previous $15.9 Million 30.27%

% of portfolio

0.07%

Previous 0.1%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$59.7 - $93.78 $244,710 - $384,404	-4,099 Reduced 2.39%	167,722 $11.1 Million
Q2 2024 Jul 25, 2024	SELL	$84.3 - $94.31 $530,162 - $593,115	-6,289 Reduced 3.53%	171,821 $15.9 Million
Q1 2024 May 08, 2024	SELL	$72.54 - $95.56 $323,746 - $426,484	-4,463 Reduced 2.44%	178,110 $17 Million
Q4 2023 Jan 31, 2024	SELL	$61.71 - $77.76 $190,066 - $239,500	-3,080 Reduced 1.66%	182,573 $13.9 Million
Q2 2023 Jul 28, 2023	SELL	$81.41 - $94.33 $1,383 - $1,603	-17 Reduced 0.01%	185,653 $17.5 Million
Q1 2023 May 03, 2023	SELL	$74.26 - $84.51 $2.19 Million - $2.49 Million	-29,523 Reduced 13.72%	185,670 $15.4 Million
Q4 2022 Jan 25, 2023	SELL	$68.3 - $87.44 $7.45 Million - $9.53 Million	-109,015 Reduced 33.63%	215,193 $0
Q3 2022 Oct 24, 2022	BUY	$82.37 - $107.29 $3,130 - $4,077	38 Added 0.01%	324,208 $26.8 Million
Q2 2022 Aug 01, 2022	SELL	$86.5 - $128.27 $1.34 Million - $1.99 Million	-15,520 Reduced 4.57%	324,170 $30.8 Million
Q1 2022 May 03, 2022	BUY	$101.96 - $128.34 $3.16 Million - $3.98 Million	31,015 Added 10.05%	339,690 $40 Million
Q4 2021 Feb 01, 2022	SELL	$106.37 - $130.68 $922,015 - $1.13 Million	-8,668 Reduced 2.73%	308,675 $40 Million
Q3 2021 Oct 26, 2021	BUY	$102.91 - $122.75 $2.72 Million - $3.24 Million	26,383 Added 9.07%	317,343 $35.9 Million
Q2 2021 Jul 22, 2021	BUY	$83.84 - $104.76 $2.22 Million - $2.77 Million	26,451 Added 10.0%	290,960 $30.1 Million
Q1 2021 Apr 12, 2021	SELL	$78.68 - $90.67 $2.24 Million - $2.58 Million	-28,458 Reduced 9.71%	264,509 $22.1 Million
Q4 2020 Jan 27, 2021	BUY	$71.69 - $91.23 $8.36 Million - $10.6 Million	116,598 Added 66.11%	292,967 $26.7 Million
Q3 2020 Oct 26, 2020	SELL	$67.19 - $87.44 $546,993 - $711,849	-8,141 Reduced 4.41%	176,369 $14.1 Million
Q2 2020 Jul 27, 2020	BUY	$57.54 - $76.95 $6.96 Million - $9.31 Million	120,933 Added 190.22%	184,510 $12.8 Million
Q1 2020 Apr 28, 2020	SELL	$52.41 - $81.0 $1.47 Million - $2.28 Million	-28,097 Reduced 30.65%	63,577 $12 Million
Q4 2019 Jan 15, 2020	SELL	$71.7 - $82.09 $2.4 Million - $2.75 Million	-33,480 Reduced 26.75%	91,674 $21.4 Million
Q3 2019 Oct 21, 2019	SELL	$61.55 - $75.43 $7.97 Million - $9.77 Million	-129,479 Reduced 50.85%	125,154 $27.5 Million
Q2 2019 Aug 07, 2019	BUY	$55.74 - $64.41 $1.62 Million - $1.87 Million	29,088 Added 12.9%	254,633 $47 Million
Q1 2019 Apr 12, 2019	SELL	$47.89 - $64.05 $20,640 - $27,605	-431 Reduced 0.19%	225,545 $43.2 Million
Q4 2018 Jan 24, 2019	BUY	$46.41 - $56.94 $4.02 Million - $4.93 Million	86,614 Added 62.15%	225,976 $34.6 Million
Q3 2018 Oct 22, 2018	BUY	$45.7 - $58.03 $1.32 Million - $1.68 Million	28,989 Added 26.26%	139,362 $24.3 Million
Q2 2018 Jul 17, 2018	BUY	$42.45 - $51.3 $698,811 - $844,500	16,462 Added 17.53%	110,373 $16.1 Million
Q1 2018 Apr 13, 2018	BUY	$37.19 - $47.45 $2.01 Million - $2.56 Million	54,039 Added 135.53%	93,911 $13.1 Million
Q4 2017 Feb 13, 2018	SELL	$33.79 - $39.39 $66,059 - $77,007	-1,955 Reduced 4.67%	39,872 $4.49 Million
Q3 2017 Oct 25, 2017	BUY	$36.29 - $38.83 $48,338 - $51,721	1,332 Added 3.29%	41,827 $4.57 Million
Q2 2017 Aug 09, 2017	BUY	N/A	40,495	40,495 $4.79 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Advisors LLC with notifications on news.

Account

Calamos Advisors LLC Edwards Lifesciences Corp Transaction History